Skip to main content
Top
Published in: International Journal of Colorectal Disease 2/2020

01-02-2020 | Metastasis | Case Report

Intestinal adenosquamous carcinoma with a synchronous skin metastasis: a immunohistochemical and molecular analysis

Authors: Paola Parente, Claudia Covelli, Paola Parrella, Tiziana Pia Latiano, Fabiola Fiordelisi, Maria Teresa Pellico, Evaristo Maiello, Paolo Graziano

Published in: International Journal of Colorectal Disease | Issue 2/2020

Login to get access

Abstract

Introduction

Intestinal adenosquamous carcinoma (ASC) is a rare colorectal neoplasm frequently occurring at onset as a locally advanced disease with distant metastases. The liver is the most common site of metastasis, followed by the peritoneum and the lung. Cutaneous metastases from usual colorectal adenocarcinoma occur in about 3% of cases, both at the time of diagnosis in advanced disease and during the follow-up. To the best of our knowledge, skin metastasis from ASC has never been described, and no biological landscape of ASC has ever been investigated.

Methods

We report a case of synchronous intestinal ASC and cutaneous single facial metastasis in a 70-year-old man with morphological, immunohistochemical, and molecular analysis of primary and metastatic lesions.

Results

Primary and metastatic ASC showed the same morphological and immunohistochemical features. Target sequencing analysis revealed, both in primary tumor and metastasis, a pathogenic KRAS gene missense mutation c.38G > A p.(Gly13Asp) and a likely pathogenic CTNNB1 gene missense mutation c.94G > A p.(Asp32Asn). A nuclear localization of β-catenin protein in adenocarcinomatous component of primary and metastatic lesions was observed on immunohistochemistry.

Conclusion

We describe a case of single synchronous facial cutaneous metastasis from intestinal ASC showing KRAS and CTNN1B mutations both on primary and metastatic lesions.
Literature
1.
go back to reference Petrelli NJ, Valle AA, Weber TK, Rodriguez-Bigas M (2009) Adenosquamous carcinoma of the colon and rectum. Dis Colon Rectum 39(11):1265–1268CrossRef Petrelli NJ, Valle AA, Weber TK, Rodriguez-Bigas M (2009) Adenosquamous carcinoma of the colon and rectum. Dis Colon Rectum 39(11):1265–1268CrossRef
2.
go back to reference Remo A, Fasasn M, Bonetti RL, varresi V, Tatangelo F et al (2019) Morphology and molecular features of rare colorectal carcinoma Histotypes. Cancers (Basel) 11(7):1036CrossRef Remo A, Fasasn M, Bonetti RL, varresi V, Tatangelo F et al (2019) Morphology and molecular features of rare colorectal carcinoma Histotypes. Cancers (Basel) 11(7):1036CrossRef
3.
go back to reference Pancione M, Remo A, Colantuoni V (2012) Genetic and epigenetic events generate multiple pathways in colorectal cancer progression. Patholog Res Int 2012:509348 Pancione M, Remo A, Colantuoni V (2012) Genetic and epigenetic events generate multiple pathways in colorectal cancer progression. Patholog Res Int 2012:509348
4.
go back to reference Masoomi H, Ziogas A, Lin BS, Barleben A, Mills S, Stamos MJ et al (2012) Population-based evaluation of adenosquamous carcinoma of the colon and rectum. Dis Colon Rectum 55(5):509–514CrossRef Masoomi H, Ziogas A, Lin BS, Barleben A, Mills S, Stamos MJ et al (2012) Population-based evaluation of adenosquamous carcinoma of the colon and rectum. Dis Colon Rectum 55(5):509–514CrossRef
5.
go back to reference Sunkara T, Caughey ME, Makkar P, John F, Gaduputi V (2018) Adenosquamous Carcinoma of the Colon. Case Rep Gastroenterol 11(3):791–796CrossRef Sunkara T, Caughey ME, Makkar P, John F, Gaduputi V (2018) Adenosquamous Carcinoma of the Colon. Case Rep Gastroenterol 11(3):791–796CrossRef
6.
go back to reference Frizelle FA, Hobday KS, Batts KP, Nelson H (2001) Adenosquamous and squamous carcinoma of the colon and upper rectum: a clinical and histopathologic study. Dis Colon Rectum 44(3):341–346CrossRef Frizelle FA, Hobday KS, Batts KP, Nelson H (2001) Adenosquamous and squamous carcinoma of the colon and upper rectum: a clinical and histopathologic study. Dis Colon Rectum 44(3):341–346CrossRef
9.
go back to reference Herxheimer G (1907) Uber heterologe cancroid. Beitr Pathol Anat 41:348–412 Herxheimer G (1907) Uber heterologe cancroid. Beitr Pathol Anat 41:348–412
10.
go back to reference Wang DY, Ye F, Lin JJ, Xu X (2017) Cutaneous metastasis: a rare phenomenon of colorectal cancer. Ann Surg Treat Res 93(5):277–280CrossRef Wang DY, Ye F, Lin JJ, Xu X (2017) Cutaneous metastasis: a rare phenomenon of colorectal cancer. Ann Surg Treat Res 93(5):277–280CrossRef
11.
go back to reference Ishida H, Yamaguchi T, Chiba K, Iijima T, Horiguchi SI (2017) A case report of ascending colon adenosquamous carcinoma with BRAF V600E mutation. Int Cancer Conf J 6(3):93–97CrossRef Ishida H, Yamaguchi T, Chiba K, Iijima T, Horiguchi SI (2017) A case report of ascending colon adenosquamous carcinoma with BRAF V600E mutation. Int Cancer Conf J 6(3):93–97CrossRef
12.
go back to reference Margonis GA, Kim Y, Sasaki K, Samaha M, Amini N, Pawlik TM (2016) Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Cancer 122(17):2698–2707CrossRef Margonis GA, Kim Y, Sasaki K, Samaha M, Amini N, Pawlik TM (2016) Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Cancer 122(17):2698–2707CrossRef
13.
go back to reference Tejpar S, Celik I, Schlichting M, Sartorius U, Bokemeyer C, Van Cutsem E (2012) Association of KRAS G13D tumor mutations with outcome in patients with metastatic colorectal cancer treated with first-line chemotherapy with or without cetuximab. J Clin Oncol 30:3570–3577CrossRef Tejpar S, Celik I, Schlichting M, Sartorius U, Bokemeyer C, Van Cutsem E (2012) Association of KRAS G13D tumor mutations with outcome in patients with metastatic colorectal cancer treated with first-line chemotherapy with or without cetuximab. J Clin Oncol 30:3570–3577CrossRef
14.
go back to reference Kim S, Jeong S (2019) Mutation hotspots in the βCatenin gene: lessons from the human cancer genome databases. Mol Cells 42(1):8–16PubMedPubMedCentral Kim S, Jeong S (2019) Mutation hotspots in the βCatenin gene: lessons from the human cancer genome databases. Mol Cells 42(1):8–16PubMedPubMedCentral
15.
go back to reference Al-Fageeh M, Li Q, Dashwood WM, Myzak MC, Dashwood RH (2004) Phosphorylation and ubiquitination of oncogenic mutants of beta-catenin containing substitutions at Asp32. Oncogene 23(28):4839–4846CrossRef Al-Fageeh M, Li Q, Dashwood WM, Myzak MC, Dashwood RH (2004) Phosphorylation and ubiquitination of oncogenic mutants of beta-catenin containing substitutions at Asp32. Oncogene 23(28):4839–4846CrossRef
16.
go back to reference Truica CI, Byers S, Gelmann EP (2000) Beta-catenin affects androgen receptor transcriptional activity and ligand specificity. Cancer Res 60(17):4709–4713PubMed Truica CI, Byers S, Gelmann EP (2000) Beta-catenin affects androgen receptor transcriptional activity and ligand specificity. Cancer Res 60(17):4709–4713PubMed
Metadata
Title
Intestinal adenosquamous carcinoma with a synchronous skin metastasis: a immunohistochemical and molecular analysis
Authors
Paola Parente
Claudia Covelli
Paola Parrella
Tiziana Pia Latiano
Fabiola Fiordelisi
Maria Teresa Pellico
Evaristo Maiello
Paolo Graziano
Publication date
01-02-2020
Publisher
Springer Berlin Heidelberg
Keyword
Metastasis
Published in
International Journal of Colorectal Disease / Issue 2/2020
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-019-03464-2

Other articles of this Issue 2/2020

International Journal of Colorectal Disease 2/2020 Go to the issue